| triamcinolone acetonide / Generic mfg. |
ACTRN12607000225415: Efficacy of intravitreal triamcinolone acetonide before pan retinal photocoagulation for improvement of visual acuity and macular edema in diabetic retinopathy |
|
|
| Recruiting | 3 | 60 | | | Eye Research Center, Farabi Eye Hospital, Tehran University of medical sciences | Diabetic macular edema in severe non proliferative diabetic retinopathy (NPDR)or proliferative diabetic retinopathy(PDR) | | | | |
NCT00105404: Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation |
|
|
| Completed | 3 | 5 | US | Triamcinolone Acetonide | National Eye Institute (NEI) | Diabetic Retinopathy, Diabetic Macular Edema, DME | | 10/06 | | |
NCT00370669: Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema |
|
|
| Unknown status | 3 | 150 | RoW | bevacizumab, triamcinolone acetonide | Shahid Beheshti University of Medical Sciences | Diabetic Macular Edema | | 02/07 | | |
NCT00600301: Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study |
|
|
| Withdrawn | 3 | | RoW | Triamcinolone Acetonide and Bevacizumab | Asociación para Evitar la Ceguera en México | Diffuse Diabetic Macular Edema | 01/08 | 01/08 | | |
NCT00367133: Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema |
|
|
| Completed | 3 | 840 | US | Standard of Care Group, soc with laser, modified ETDRS photocoagulation, 1mg triamcinolone acetonide, corticosteroid, 4mg triamcinolone acetonide | Jaeb Center for Health Research, National Eye Institute (NEI), Allergan | Diabetic Macular Edema | 05/08 | 10/08 | | |
| Completed | 3 | 292 | Europe | Triamcinolone Acetonide, Trigon Depot, Grid laser, Sham Injection | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA, Fondo de Investigacion Sanitaria | Diabetes Mellitus, Macular Edema | 07/09 | 07/09 | | |
| Completed | 3 | 333 | US | Ranibizumab, Lucentis™, Triamcinolone Acetonide, corticosteroid, Sham injection, Focal/grid laser | Jaeb Center for Health Research, National Eye Institute (NEI), Genentech, Inc., Allergan | Proliferative Diabetic Retinopathy, Diabetic Macular Edema | 10/09 | 07/10 | | |
NCT00444600: Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema |
|
|
| Completed | 3 | 691 | US | Triamcinolone Acetonide + laser, corticosteroid, Ranibizumab + laser, Lucentis, anti-VEGF drug, Sham injection + laser, placebo, Ranibizumab + deferred laser | Jaeb Center for Health Research, National Eye Institute (NEI), Allergan, Genentech, Inc. | Diabetic Retinopathy, Diabetic Macular Edema | 12/09 | 02/14 | | |
NCT00148330: Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study |
|
|
| Completed | 2/3 | 64 | RoW | Triamcinolone acetate, Kenacort 40© | University of Sydney | Diabetic Macular Oedema | 07/08 | 07/08 | | |
NCT00148265: A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema |
|
|
| Completed | 2/3 | 54 | RoW | Triamcinolone acetate, Kenacort 40© | University of Sydney, The University of Western Australia, University of Melbourne, Marsden Eye Specialists | Diabetic Macular Oedema | 05/09 | 05/09 | | |
| Completed | 2/3 | 100 | NA | Bevacizumab Injection [Avastin] (IVB-I), Avastin®, Triamcinolone Acetonide 10mg/mL (IVT-II), OPTHTAAC®, Bevacizumab Injection [Avastin] (IVB-III) | University of Sao Paulo | Diabetic Macular Edema | 04/17 | 12/17 | | |
